Annals of Hepatology

Is FIB-4 the right tool for screening for liver fibrosis? Leen J.M. Heyens; Demi P.A. van Malde; Gediz Dogay Us; Francesco Innocenti; Mathieu Struyve; Christophe Van Steenkiste; Sven Francque; Geert Robaeys; Ger H. Koek;

Does the hepatologist still need to rely on aminotransferases in clinical practice? A reappraisal of the role of a classic biomarker in the diagnosis and clinical management of chronic liver diseases Patrizia Burra; Calogero Cammà; Pietro Invernizzi; Fabio Marra; Maurizio Pompili;

Long-term systemic effects of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD/MAFLD) in children: a systematic review of persistence and progression into adulthood Beatriz Rey-Garcia; Maria Teresa Reyes-Chacon; Eduardo Rosas-Blum; Marie Leiner;